Administration, OralHalf-LifeArea Under CurveDrug Administration ScheduleDose-Response Relationship, DrugDrug InteractionsDouble-Blind MethodBiological AvailabilityInjections, IntravenousMetabolic Clearance RateNorpregnenesBlisterCross-Over StudiesTime FactorsTolmetinChromatography, High Pressure LiquidDelayed-Action PreparationsBiotransformationIndansInfusions, IntravenousInjections, IntramuscularTreatment OutcomeAnti-Infective AgentsAcetaminophenTissue DistributionInjections, SubcutaneousKetoconazoleDrug CombinationsMacaca fascicularisProthrombin TimeDrug EvaluationAntifungal AgentsAnti-Bacterial AgentsOfloxacinCytochrome P-450 CYP2D6Immunization ScheduleLiverTabletsDrug Therapy, CombinationFecesPiperidinesAdministration, TopicalCytochrome P-450 CYP3ATheophyllineKineticsCephalosporinsPyridinesAntibodies, MonoclonalAntineoplastic AgentsAnalgesicsRats, Sprague-DawleyMice, Inbred BALB CMice, Inbred StrainsNeoplasmsPregnancyBlood ProteinsNeoplasm TransplantationRabbitsAnalysis of VarianceBody WeightMice, Inbred C3HAntiviral AgentsModels, BiologicalRadiation DosageLethal Dose 50Recombinant ProteinsLungDisease Models, AnimalBlood PressureInfant, NewbornRadiometryMice, Inbred C57BLDose-Response Relationship, RadiationDose FractionationRadiotherapy DosageRadiotherapy Planning, Computer-AssistedBody BurdenThermoluminescent DosimetryRelative Biological EffectivenessMetered Dose InhalersRadiation MonitoringRadiation InjuriesRadiotherapy, Intensity-ModulatedRats, WistarAntineoplastic Combined Chemotherapy ProtocolsPhantoms, ImagingInjections, IntraperitonealAdministration, InhalationRadioisotopesIodine RadioisotopesOrgans at RiskDose-Response Relationship, ImmunologicDogsRandom AllocationProspective StudiesDrug SynergismWhole-Body CountingKidneyDrug TolerancePlacebos